Altogether, these observations indicate an important role of CXCR4 signalling in pancreatic cancer survival, proliferation, invasion, and metastasis, suggesting this signalling axis as a potential target for cancer therapy. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.